Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.28 trillion and total revenue of $116.52 billion.
Market Cap
1.28T
Revenue
116.52B
Profits
-35.49B
PE Ratio
n/a
Profit Margin
-30.46%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.44B | 2.53% | 1,230,676 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 96.65B | 6.69% | 16,856,761 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 80.63B | 3.25% | 621,972 | 15.53B |
| 4 | ARGX | argenx SE | 54.82B | 5.34% | 536,442 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 43.72B | 3.87% | 408,183 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 42.13B | 7.91% | 2,735,548 | - |
| 7 | RPRX | Royalty Pharma plc | 35.79B | 3.29% | 2,489,430 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.87B | -1.11% | 1,458,009 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.22B | 0.63% | 3,654,251 | 7.53M |
| 10 | INCY | Incyte Corporation | 23.64B | 2.97% | 1,341,789 | 5.82B |
| 11 | GMAB | Genmab A/S | 23.37B | 1.48% | 3,780,311 | 4.13B |
| 12 | BNTX | BioNTech SE | 22.90B | 2.20% | 1,835,790 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.89B | 0.40% | 2,612,486 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.95B | 2.73% | 2,136,862 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 15.39B | 1.90% | 394,722 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.12B | 1.53% | 2,202,255 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.88B | 2.56% | 663,214 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.21B | -0.57% | 2,732,825 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.87B | 3.34% | 6,227,058 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.59B | 3.88% | 549,475 | 830.81M |
| 21 | TECH | Bio-Techne Corporation | 11.38B | 0.12% | 3,210,399 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.93B | 3.24% | 3,474,611 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.80B | 4.57% | 407,947 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 10.42B | 4.00% | 1,948,485 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.63B | 1.61% | 195,436 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.43B | 4.99% | 705,125 | 105.00M |
| 27 | IBRX | ImmunityBio, Inc. | 9.29B | 4.16% | 14,110,326 | 165.79M |
| 28 | TWST | Twist Bioscience Corporation | 8.95B | 2.10% | 2,020,233 | 431.80M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 8.93B | 2.64% | 774,456 | 281.99M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.89B | 2.08% | 1,050,347 | 67.67M |
| 31 | CAI | Caris Life Sciences, Inc. | 8.79B | 1.30% | 3,537,158 | 989.61M |
| 32 | SYRE | Spyre Therapeutics, Inc. | 8.54B | 7.88% | 1,708,497 | - |
| 33 | AXSM | Axsome Therapeutics, Inc. | 8.36B | 2.42% | 653,794 | 776.57M |
| 34 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.32B | 2.95% | 1,742,402 | 669.50M |
| 35 | ABVX | ABIVAX Société Anonyme | 8.15B | 5.83% | 1,604,442 | 5.33M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.73B | 2.31% | 1,057,747 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.54B | 2.30% | 2,486,649 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | 1.66% | 885,843 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.73B | 4.57% | 9,754,900 | 324.97M |
| 40 | BLTE | Belite Bio, Inc | 6.22B | 4.83% | 209,728 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | 2.23% | 876,986 | 239.92M |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 6.11B | 3.07% | 171,729 | 290.54M |
| 43 | IMVT | Immunovant, Inc. | 5.91B | 3.51% | 1,448,983 | - |
| 44 | KOD | Kodiak Sciences Inc. | 5.83B | 1.77% | 865,823 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | 3.44% | 633,301 | 618.07M |
| 46 | CGON | CG Oncology, Inc. | 5.49B | 3.29% | 766,679 | 6.23M |
| 47 | COGT | Cogent Biosciences, Inc. | 5.42B | 4.10% | 2,311,785 | - |
| 48 | MANE | Veradermics, Incorporated | 5.31B | 3.95% | 1,070,020 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.25B | 2.26% | 964,655 | 1.01B |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.24B | 6.19% | 787,723 | - |
| 51 | ERAS | Erasca, Inc. | 5.11B | 7.34% | 4,199,413 | - |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.04B | 2.78% | 1,614,182 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.93B | 3.58% | 2,057,649 | 591.33M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.82B | -0.32% | 2,156,292 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.71B | 6.43% | 1,746,260 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.40B | 5.65% | 1,865,286 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.32B | 4.83% | 2,171,190 | - |
| 58 | TNGX | Tango Therapeutics, Inc. | 4.26B | 7.31% | 2,674,926 | 53.81M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 4.13B | 2.92% | 4,490,704 | 463.98M |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.04B | 7.96% | 1,974,820 | 10.35M |
| 61 | ABCL | AbCellera Biologics Inc. | 3.79B | -1.84% | 4,263,275 | 66.17M |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.75B | 3.91% | 304,952 | 890.79M |
| 63 | LEGN | Legend Biotech Corporation | 3.68B | 1.93% | 1,137,027 | 1.27B |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.52B | 3.23% | 1,675,477 | 1.14B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.51B | 3.39% | 990,760 | 7.50M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.41B | 4.58% | 962,254 | 234.13M |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.35B | 6.82% | 1,495,347 | 148.00K |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | 2.20% | 898,979 | 606.33M |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.12B | 6.63% | 4,656,225 | - |
| 70 | IRON | Disc Medicine, Inc. | 3.05B | 0.70% | 2,205,540 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.04B | 6.83% | 3,405,265 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.03B | 4.93% | 1,824,100 | 3.60M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.02B | 7.27% | 6,242,253 | 117.00M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.02B | 6.59% | 1,938,204 | - |
| 75 | CELC | Celcuity Inc. | 2.94B | 5.04% | 2,382,928 | - |
| 76 | NRIX | Nurix Therapeutics, Inc. | 2.85B | 4.69% | 3,979,020 | 701.94M |
| 77 | ZLAB | Zai Lab Limited | 2.82B | 4.24% | 805,466 | 449.61M |
| 78 | MBX | MBX Biosciences, Inc. | 2.58B | 1.94% | 808,027 | - |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.57B | 5.03% | 1,083,657 | 7.12M |
| 80 | VRDN | Viridian Therapeutics, Inc. | 2.54B | 7.84% | 1,974,589 | 71.13M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.52B | 1.45% | 2,896,317 | 512.28M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.49B | 3.06% | 1,479,699 | 156.04M |
| 83 | PGEN | Precigen, Inc. | 2.45B | 2.55% | 6,115,574 | 85.72M |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | 14.20% | 10,214,966 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.38B | 2.09% | 1,100,388 | 158.00K |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 3.09% | 798,583 | 959.90M |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.52% | 593,682 | 311.51M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 1.39% | 20,800,906 | 54.86M |
| 89 | AGIO | Agios Pharmaceuticals, Inc. | 2.19B | 4.99% | 1,518,815 | 98.34M |
| 90 | PHVS | Pharvaris N.V. | 2.17B | 3.80% | 1,027,710 | - |
| 91 | FTRE | Fortrea Holdings Inc. | 2.17B | 1.61% | 2,377,021 | 2.68B |
| 92 | VERA | Vera Therapeutics, Inc. | 2.17B | 3.94% | 1,189,446 | - |
| 93 | VCEL | Vericel Corporation | 2.08B | 0.52% | 475,254 | 306.30M |
| 94 | IMNM | Immunome, Inc. | 2.04B | 6.86% | 2,029,591 | 4.02M |
| 95 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | 8.12% | 3,327,331 | 1.97B |
| 96 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | 0.28% | 1,074,929 | 6.13M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.95B | 3.22% | 293,686 | 1.13B |
| 98 | ZYME | Zymeworks Inc. | 1.91B | 5.36% | 3,130,337 | 37.13M |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 3.15% | 1,000,796 | - |
| 100 | NVAX | Novavax, Inc. | 1.89B | 5.64% | 6,526,341 | 413.80M |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | 3.00% | 2,022,517 | 208.78M |
| 102 | XNCR | Xencor, Inc. | 1.85B | 7.55% | 884,200 | 104.97M |
| 103 | SEPN | Septerna, Inc. | 1.84B | 8.16% | 418,302 | 98.88M |
| 104 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 5.50% | 549,013 | 1.00M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.83B | 7.82% | 1,827,815 | - |
| 106 | VIR | Vir Biotechnology, Inc. | 1.82B | 5.19% | 1,343,319 | 303.23M |
| 107 | MAZE | Maze Therapeutics, Inc. | 1.80B | 9.26% | 1,569,136 | 20.00M |
| 108 | PVLA | Palvella Therapeutics, Inc. | 1.79B | 0.78% | 266,371 | - |
| 109 | BHVN | Biohaven Ltd. | 1.78B | 4.05% | 1,527,914 | - |
| 110 | STOK | Stoke Therapeutics, Inc. | 1.72B | 7.21% | 2,458,618 | 27.59M |
| 111 | URGN | UroGen Pharma Ltd. | 1.71B | 2.52% | 747,756 | 188.73M |
| 112 | IMCR | Immunocore Holdings plc | 1.68B | 9.28% | 942,092 | 430.78M |
| 113 | NUVB | Nuvation Bio Inc. | 1.67B | 6.47% | 6,853,163 | 169.90M |
| 114 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 12.77% | 1,579,956 | - |
| 115 | NTLA | Intellia Therapeutics, Inc. | 1.66B | 2.25% | 3,417,113 | 59.51M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.66B | 2.71% | 522,700 | 26.48M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.65B | 5.52% | 323,870 | - |
| 118 | GPCR | Structure Therapeutics Inc. | 1.63B | 3.95% | 1,409,398 | - |
| 119 | MESO | Mesoblast Limited | 1.60B | 3.85% | 245,569 | 120.25M |
| 120 | COAG | Hemab Therapeutics Holdings, Inc. | 1.60B | 6.48% | 397,749 | - |
| 121 | QURE | uniQure N.V. | 1.58B | 2.32% | 1,414,729 | 18.67M |
| 122 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | 6.30% | 3,540,446 | 717.00M |
| 123 | ABSI | Absci Corporation | 1.56B | 6.21% | 2,826,011 | 1.56M |
| 124 | INVA | Innoviva, Inc. | 1.54B | 0.95% | 507,563 | 440.00M |
| 125 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | 13.70% | 1,033,330 | - |
| 126 | OCUL | Ocular Therapeutix, Inc. | 1.46B | 5.72% | 2,617,018 | 52.06M |
| 127 | AAPG | Ascentage Pharma Group International | 1.43B | 3.65% | 4,888 | 94.61M |
| 128 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 8.33% | 2,019,211 | - |
| 129 | KRSA | Korsana Biosciences, Inc. | 1.41B | -1.31% | 105,817 | - |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.41B | 2.69% | 8,055,414 | 20.00M |
| 131 | TYRA | Tyra Biosciences, Inc. | 1.41B | 5.84% | 607,588 | - |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 6.14% | 221,421 | 1.30M |
| 133 | ANAB | AnaptysBio, Inc. | 1.36B | -7.74% | 1,205,982 | 106.09M |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 4.31% | 10,925,838 | 5.49M |
| 135 | NKTR | Nektar Therapeutics | 1.34B | 7.04% | 1,057,590 | 54.59M |
| 136 | LBRX | LB Pharmaceuticals Inc | 1.32B | 5.64% | 388,414 | - |
| 137 | GHRS | GH Research PLC | 1.32B | 4.84% | 277,232 | - |
| 138 | DMRA | Damora Therapeutics, Inc. | 1.28B | 7.37% | 242,319 | - |
| 139 | KARD | Kardigan, Inc. | 1.26B | 4.40% | 768,711 | - |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.21B | 5.04% | 493,417 | - |
| 141 | NBTX | Nanobiotix S.A. | 1.21B | 14.52% | 137,892 | 13.15M |
| 142 | SVRA | Savara Inc. | 1.21B | 2.81% | 4,421,630 | - |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.21B | 3.72% | 832,887 | - |
| 144 | OMER | Omeros Corporation | 1.20B | 1.22% | 725,295 | 38.42M |
| 145 | SNDX | Syndax Pharmaceuticals, Inc. | 1.18B | 1.22% | 3,912,321 | 252.25M |
| 146 | SLN | Silence Therapeutics plc | 1.18B | 0.15% | 13,910,650 | 615.00K |
| 147 | VSTM | Verastem, Inc. | 1.13B | 8.35% | 3,964,602 | 87.53M |
| 148 | VOR | Vor Biopharma Inc. | 1.13B | 5.49% | 795,983 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.09B | 5.57% | 217,517 | - |
| 150 | REPL | Replimune Group, Inc. | 1.08B | 3.35% | 1,388,896 | - |
| 151 | JANX | Janux Therapeutics, Inc. | 1.05B | 2.75% | 869,443 | 24.00M |
| 152 | CTY | City Therapeutics, Inc. | 1.04B | -2.94% | 632,844 | 14.34M |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.03B | 8.38% | 143,155 | - |
| 154 | IMTX | Immatics N.V. | 1.03B | 6.52% | 1,487,247 | 47.65M |
| 155 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | 6.64% | 147,782 | - |
| 156 | MNKD | MannKind Corporation | 996.78M | 0.32% | 2,170,259 | 393.63M |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 969.16M | 6.57% | 1,865,616 | 28.73M |
| 158 | ANRO | Alto Neuroscience, Inc. | 957.90M | 6.97% | 869,407 | - |
| 159 | MGTX | MeiraGTx Holdings plc | 957.55M | 5.50% | 755,861 | 397.50M |
| 160 | CGEM | Cullinan Therapeutics, Inc. | 954.38M | 6.08% | 694,005 | - |
| 161 | JBIO | Jade Biosciences, Inc. | 945.06M | 7.45% | 881,296 | - |
| 162 | AVBP | ArriVent BioPharma, Inc. | 929.45M | 5.07% | 817,835 | - |
| 163 | ODTX | Odyssey Therapeutics, Inc. | 909.97M | 4.92% | 317,338 | 99.00K |
| 164 | RIGL | Rigel Pharmaceuticals, Inc. | 898.69M | 2.98% | 366,186 | 276.79M |
| 165 | AKTS | Aktis Oncology, Inc. | 894.36M | 6.42% | 343,482 | 10.06M |
| 166 | KURA | Kura Oncology, Inc. | 887.83M | 6.62% | 1,543,379 | 77.23M |
| 167 | MLTX | MoonLake Immunotherapeutics | 878.30M | 5.85% | 1,237,562 | - |
| 168 | SGP | SpyGlass Pharma, Inc. | 875.00M | 6.06% | 99,257 | - |
| 169 | ALMS | Alumis Inc. | 867.22M | 5.68% | 1,535,199 | 7.40M |
| 170 | CRVS | Corvus Pharmaceuticals, Inc. | 860.56M | 6.01% | 1,066,872 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 856.68M | 2.36% | 2,114,272 | 181.72M |
| 172 | SLBT | SL Science Holding Limited | 855.40M | -1.96% | 22,659 | 3.27M |
| 173 | OBX | Obsidian Therapeutics, Inc. | 818.49M | 10.97% | 410,907 | - |
| 174 | ARDX | Ardelyx, Inc. | 799.89M | 3.88% | 3,964,188 | 450.89M |
| 175 | HELP | Helus Pharma Inc. | 799.28M | 2.34% | 2,365,697 | - |
| 176 | GERN | Geron Corporation | 796.67M | 3.33% | 3,564,917 | 204.56M |
| 177 | APMD | Apnimed, Inc. | 770.59M | 11.51% | 311,028 | 115.12M |
| 178 | IVA | Inventiva S.A. | 769.82M | 9.40% | 2,638,052 | 2.81M |
| 179 | IAM | Iambic Therapeutics, Inc. | 758.89M | -2.02% | 981,065 | 18.25M |
| 180 | IMMX | Immix Biopharma, Inc. | 738.67M | 8.39% | 1,226,136 | - |
| 181 | ANNX | Annexon, Inc. | 726.09M | -4.49% | 6,370,008 | - |
| 182 | FDMT | 4D Molecular Therapeutics, Inc. | 723.70M | 6.59% | 725,369 | 92.01M |
| 183 | OABI | OmniAb, Inc. | 721.14M | 5.76% | 1,930,823 | 38.46M |
| 184 | SANA | Sana Biotechnology, Inc. | 706.49M | 2.61% | 3,524,827 | - |
| 185 | LXRX | Lexicon Pharmaceuticals, Inc. | 703.03M | 1.94% | 1,410,970 | 41.47M |
| 186 | PRME | Prime Medicine, Inc. | 697.38M | 2.35% | 3,688,228 | 4.07M |
| 187 | DSGN | Design Therapeutics, Inc. | 694.66M | 4.32% | 580,794 | - |
| 188 | SGMT | Sagimet Biosciences Inc. | 690.65M | 9.93% | 2,175,257 | - |
| 189 | SLDB | Solid Biosciences Inc. | 686.24M | 8.11% | 1,465,021 | - |
| 190 | ANL | Adlai Nortye Group Ltd. | 685.19M | 2.50% | 242,556 | 18.06M |
| 191 | AURA | Aura Biosciences, Inc. | 680.30M | 4.29% | 1,164,028 | - |
| 192 | PHAR | Pharming Group N.V. | 678.44M | 7.03% | 6,279 | 366.48M |
| 193 | WVE | Wave Life Sciences, Inc. | 673.90M | 7.89% | 3,615,826 | 65.37M |
| 194 | NVCT | Nuvectis Pharma, Inc. | 670.85M | 8.71% | 148,772 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 669.90M | -1.51% | 2,111,935 | - |
| 196 | DNA | Ginkgo Bioworks Holdings, Inc. | 663.98M | -2.09% | 2,487,282 | 132.42M |
| 197 | AVTX | Avalo Therapeutics, Inc. | 662.87M | 6.64% | 1,869,561 | 59.00K |
| 198 | CADL | Candel Therapeutics, Inc. | 661.12M | 5.24% | 1,126,151 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 654.23M | 1.31% | 242,073 | 109.82M |
| 200 | ATTO | Attovia Therapeutics, Inc. | 640.94M | 1.08% | 448,437 | 1.80M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 634.36M | 1.97% | 1,871,544 | - |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 621.75M | 3.05% | 432,228 | 136.07M |
| 203 | CLYM | Climb Bio, Inc. | 620.31M | 11.00% | 1,369,064 | - |
| 204 | MDXG | MiMedx Group, Inc. | 616.57M | -3.65% | 1,633,204 | 355.17M |
| 205 | CRMD | CorMedix Inc. | 590.04M | 2.57% | 971,648 | 462.25M |
| 206 | STTK | Shattuck Labs, Inc. | 586.12M | 8.75% | 1,555,643 | 1.00M |
| 207 | PHAT | Phathom Pharmaceuticals, Inc. | 580.63M | 4.28% | 724,282 | 239.66M |
| 208 | DBVT | DBV Technologies S.A. | 571.22M | 6.13% | 210,566 | 5.04M |
| 209 | CBIO | Crescent Biopharma, Inc. | 559.41M | 5.74% | 299,610 | 11.88M |
| 210 | DRUG | Bright Minds Biosciences Inc. | 556.44M | 2.56% | 94,681 | - |
| 211 | PBYI | Puma Biotechnology, Inc. | 555.43M | 5.39% | 364,915 | 231.24M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 554.94M | 8.33% | 3,499,166 | 8.22M |
| 213 | ETRA | Electra Therapeutics, Inc. | 552.98M | 2.32% | 177,717 | - |
| 214 | CTMX | CytomX Therapeutics, Inc. | 546.93M | 7.26% | 4,103,534 | 18.30M |
| 215 | FTH | Faeth Therapeutics, Inc. | 537.22M | 6.94% | 805,987 | - |
| 216 | VALN | Valneva SE | 536.07M | 3.27% | 13,029 | 163.30M |
| 217 | ENTX | Entera Bio Ltd. | 525.25M | 2.72% | 791,916 | 42.00K |
| 218 | NGNE | Neurogene Inc. | 508.29M | 5.09% | 205,853 | 925.00K |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 502.90M | 9.21% | 938,688 | - |
| 220 | ARVN | Arvinas, Inc. | 500.86M | 5.51% | 540,849 | 316.70M |
| 221 | MNPR | Monopar Therapeutics Inc. | 498.24M | 3.86% | 89,529 | - |
| 222 | RGNX | REGENXBIO Inc. | 488.50M | 3.50% | 1,315,113 | 174.48M |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 467.54M | 10.17% | 168,155 | - |
| 224 | OCS | Oculis Holding AG | 462.37M | 2.32% | 318,663 | 1.45M |
| 225 | OVID | Ovid Therapeutics Inc. | 460.90M | 8.76% | 3,668,556 | 1.58M |
| 226 | ALLO | Allogene Therapeutics, Inc. | 459.50M | 2.31% | 4,579,501 | 4.64M |
| 227 | MPLT | MapLight Therapeutics, Inc. | 457.94M | 3.00% | 355,012 | - |
| 228 | BLSM | BlossomHill Therapeutics, Inc. | 457.70M | 1.69% | 74,918 | - |
| 229 | ALT | Altimmune, Inc. | 447.39M | 3.14% | 2,298,644 | 31.00K |
| 230 | EIKN | Eikon Therapeutics, Inc. | 443.07M | 6.23% | 336,536 | - |
| 231 | AUTL | Autolus Therapeutics plc | 441.83M | 4.40% | 2,636,841 | 117.39M |
| 232 | PRTA | Prothena Corporation plc | 436.36M | 0.24% | 528,976 | 54.53M |
| 233 | PROK | ProKidney Corp. | 435.34M | 3.23% | 1,391,805 | 818.00K |
| 234 | ASMB | Assembly Biosciences, Inc. | 431.44M | 5.11% | 222,789 | 74.85M |
| 235 | AGMB | AgomAb Therapeutics NV | 429.93M | 6.08% | 35,303 | - |
| 236 | TECX | Tectonic Therapeutic, Inc. | 426.66M | 3.19% | 143,666 | - |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | 1.42% | 1,541,686 | 116.93M |
| 238 | YDES | YD Bio Limited | 413.66M | -4.58% | 178,133 | 1.24M |
| 239 | EDIT | Editas Medicine, Inc. | 396.24M | 6.61% | 2,266,487 | 47.01M |
| 240 | INDP | Indaptus Therapeutics, Inc. | 394.40M | 8.42% | 218,414 | - |
| 241 | CCCC | C4 Therapeutics, Inc. | 388.76M | 9.34% | 3,689,396 | 35.04M |
| 242 | TRXB | TRex Bio, Inc. | 388.75M | -2.43% | 64,232 | - |
| 243 | RZLT | Rezolute, Inc. | 388.12M | - | 1,225,180 | - |
| 244 | CAPR | Capricor Therapeutics, Inc. | 384.30M | -0.60% | 2,054,461 | 11.13M |
| 245 | ZURA | Zura Bio Limited | 383.32M | 4.99% | 3,318,586 | - |
| 246 | SCTX | Scribe Therapeutics Inc. | 375.04M | 2.22% | 203,640 | 33.30M |
| 247 | KYTX | Kyverna Therapeutics, Inc. | 373.53M | 3.60% | 766,272 | - |
| 248 | FENC | Fennec Pharmaceuticals Inc. | 366.80M | 1.85% | 70,983 | 59.22M |
| 249 | PRLD | Prelude Therapeutics Incorporated | 363.57M | 4.13% | 359,935 | 22.42M |
| 250 | RLMD | Relmada Therapeutics, Inc. | 358.41M | 6.33% | 738,435 | - |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 357.71M | 1.59% | 288,828 | - |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 349.81M | 3.01% | 992,355 | 31.98M |
| 253 | VTVT | vTv Therapeutics Inc. | 345.97M | 3.36% | 21,207 | 36.84M |
| 254 | GALT | Galectin Therapeutics Inc. | 345.91M | -1.86% | 200,185 | - |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 339.89M | 2.28% | 164,921 | 65.26M |
| 256 | IRD | Opus Genetics, Inc. | 333.62M | 4.97% | 1,461,227 | 9.86M |
| 257 | NAUT | Nautilus Biotechnology, Inc. | 324.50M | -3.04% | 10,015,351 | 190.00K |
| 258 | ARTV | Artiva Biotherapeutics, Inc. | 320.72M | 11.38% | 449,835 | 251.00K |
| 259 | CTNM | Contineum Therapeutics, Inc. | 318.27M | 13.71% | 2,200,899 | - |
| 260 | BNTC | Benitec Biopharma Inc. | 315.34M | 8.13% | 347,595 | - |
| 261 | ARCT | Arcturus Therapeutics Holdings Inc. | 312.09M | 5.37% | 869,430 | 29.37M |
| 262 | TTRX | Turn Therapeutics Inc. | 311.88M | -2.51% | 76,906 | - |
| 263 | IKT | Inhibikase Therapeutics, Inc. | 311.35M | 3.95% | 363,420 | 1.00 |
| 264 | XFOR | X4 Pharmaceuticals, Inc. | 299.42M | 9.82% | 593,313 | 15.85M |
| 265 | IPSC | Century Therapeutics, Inc. | 296.96M | 11.56% | 1,402,633 | 109.16M |
| 266 | SRZN | Surrozen, Inc. | 295.48M | 5.45% | 323,894 | 11.51M |
| 267 | ALEC | Alector, Inc. | 292.07M | 1.03% | 2,021,249 | 13.86M |
| 268 | AGEN | Agenus Inc. | 289.03M | 3.88% | 827,183 | 132.69M |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 283.83M | 0.54% | 757,122 | 80.00M |
| 270 | VOGX | Vogenx, Inc. | 278.53M | 17.78% | 70,994 | - |
| 271 | OCGN | Ocugen, Inc. | 275.53M | 3.20% | 6,661,841 | 4.58M |
| 272 | CABA | Cabaletta Bio, Inc. | 272.97M | 8.78% | 3,462,621 | - |
| 273 | CUVL | Clinuvel Pharmaceuticals Limited | 263.37M | -0.95% | 3,103 | 65.05M |
| 274 | ABEO | Abeona Therapeutics Inc. | 263.05M | 4.31% | 1,393,701 | 25.52M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 262.04M | 10.77% | 814,422 | 114.70K |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 256.87M | 4.46% | 1,888,232 | - |
| 277 | QTTB | Q32 Bio Inc. | 256.61M | 10.65% | 505,501 | 53.74M |
| 278 | LRMR | Larimar Therapeutics, Inc. | 254.69M | 15.09% | 1,810,734 | - |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 252.13M | 1.96% | 857,154 | 215.72M |
| 280 | BCYC | Bicycle Therapeutics plc | 251.97M | 1.84% | 488,096 | 61.21M |
| 281 | VCRE | Vicore Pharma Holding AB (publ) | 249.48M | 1.69% | 18,812 | 412.09K |
| 282 | PALI | Palisade Bio, Inc. | 249.21M | 6.72% | 2,823,240 | 500.00K |
| 283 | LXEO | Lexeo Therapeutics, Inc. | 247.77M | 9.42% | 1,275,661 | - |
| 284 | ACIU | AC Immune SA | 247.57M | 2.26% | 140,103 | 21.67M |
| 285 | FATE | Fate Therapeutics, Inc. | 246.83M | 10.75% | 1,772,276 | 6.49M |
| 286 | LCTX | Lineage Cell Therapeutics, Inc. | 245.98M | 2.08% | 1,631,237 | 13.08M |
| 287 | IMRX | Immuneering Corporation | 241.32M | 1.91% | 926,841 | - |
| 288 | GLSI | Greenwich LifeSciences, Inc. | 238.37M | 6.77% | 101,569 | - |
| 289 | LYEL | Lyell Immunopharma, Inc. | 237.70M | 10.23% | 158,614 | 27.00K |
| 290 | IFRX | InflaRx N.V. | 226.95M | 6.21% | 724,081 | -11.54K |
| 291 | ZNTL | Zentalis Pharmaceuticals, Inc. | 226.27M | 3.91% | 1,557,944 | 26.87M |
| 292 | KROS | Keros Therapeutics, Inc. | 226.03M | 3.07% | 153,373 | 15.01M |
| 293 | MGNX | MacroGenics, Inc. | 222.31M | 4.80% | 325,408 | 175.14M |
| 294 | PYXS | Pyxis Oncology, Inc. | 219.80M | 4.55% | 1,100,333 | 11.04M |
| 295 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 218.07M | -4.56% | 660,931 | - |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 215.46M | 1.28% | 45,028 | 1.80M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 212.71M | 3.13% | 702,710 | 80.62M |
| 298 | CGEN | Compugen Ltd. | 202.71M | 8.63% | 923,275 | 74.00M |
| 299 | PEPG | PepGen Inc. | 198.77M | 6.30% | 2,768,822 | - |
| 300 | CAMP | Camp4 Therapeutics Corporation | 198.30M | 0.64% | 89,173 | 4.22M |
| 301 | EVMN | Evommune, Inc. | 195.25M | 2.09% | 382,462 | 10.00M |
| 302 | PRQR | ProQR Therapeutics N.V. | 194.75M | 5.34% | 938,571 | 21.05M |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 193.48M | 5.18% | 168,133 | 1.48M |
| 304 | STRO | Sutro Biopharma, Inc. | 191.35M | 2.49% | 273,807 | 45.70M |
| 305 | YARW | Yarrow Bioscience, Inc. | 187.95M | 1.10% | 105,876 | - |
| 306 | IVVD | Invivyd, Inc. | 187.64M | 4.36% | 2,273,255 | 58.37M |
| 307 | SION | Sionna Therapeutics, Inc. | 187.63M | 3.49% | 1,068,718 | - |
| 308 | ACOG | Alpha Cognition Inc. | 187.51M | 1.29% | 97,851 | 15.26M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 183.42M | 4.40% | 740,338 | - |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 181.86M | 5.98% | 417,759 | 7.15M |
| 311 | DTIL | Precision BioSciences, Inc. | 181.07M | 5.98% | 213,653 | 45.06M |
| 312 | TRDA | Entrada Therapeutics, Inc. | 179.92M | 3.53% | 403,054 | 4.69M |
| 313 | ORMP | Oramed Pharmaceuticals Inc. | 172.63M | 2.22% | 142,342 | 2.00M |
| 314 | ALXO | ALX Oncology Holdings Inc. | 171.46M | 8.77% | 871,501 | - |
| 315 | ADAG | Adagene Inc. | 167.86M | 9.17% | 92,709 | 9.29M |
| 316 | NGEN | NervGen Pharma Corp. | 165.58M | - | 227,790 | - |
| 317 | NBP | NovaBridge Biosciences | 165.30M | 9.62% | 657,924 | - |
| 318 | MDWD | MediWound Ltd. | 156.21M | -4.41% | 233,112 | 11.86M |
| 319 | CHRS | Coherus Oncology, Inc. | 154.50M | 4.31% | 967,662 | 50.94M |
| 320 | UPB | Upstream Bio, Inc. | 154.45M | 0.71% | 1,676,022 | 3.16M |
| 321 | TARA | Protara Therapeutics, Inc. | 151.28M | 9.87% | 1,500,380 | - |
| 322 | CMPX | Compass Therapeutics, Inc. | 150.07M | -0.20% | 1,883,130 | 850.00K |
| 323 | MSLE | Satellos Bioscience Inc. | 146.64M | 7.45% | 13,544 | - |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 145.72M | 13.84% | 784,519 | - |
| 325 | VRXA | Veraxa Biotech AG | 142.82M | 1.00% | 126,227 | 29.54K |
| 326 | IPHA | Innate Pharma S.A. | 142.11M | 8.08% | 13,132 | 11.21M |
| 327 | MOLN | Molecular Partners AG | 141.62M | 1.09% | - | 856.30K |
| 328 | KRRO | Korro Bio, Inc. | 139.01M | 5.95% | 235,013 | 2.38M |
| 329 | MENS | Jyong Biotech Ltd. | 138.07M | -3.63% | 27,310 | - |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 137.85M | 2.37% | 660,971 | 1.50M |
| 331 | RNA | Atrium Therapeutics, Inc. | 136.50M | 4.86% | 289,487 | 35.84M |
| 332 | VYGR | Voyager Therapeutics, Inc. | 134.94M | 6.83% | 1,126,418 | 34.46M |
| 333 | RTSN | Retension Pharmaceuticals, Inc. | 134.81M | -0.92% | 97,455 | - |
| 334 | CDXS | Codexis, Inc. | 134.69M | -6.82% | 1,288,949 | 77.68M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 134.34M | 5.64% | 129,743 | - |
| 336 | TLSA | Tiziana Life Sciences Ltd | 129.31M | - | 299,453 | - |
| 337 | OTLK | Outlook Therapeutics, Inc. | 126.59M | 5.48% | 3,311,825 | -1.16M |
| 338 | AVXL | Anavex Life Sciences Corp. | 126.07M | 8.80% | 1,672,722 | - |
| 339 | NKTX | Nkarta, Inc. | 124.63M | -0.57% | 1,144,152 | - |
| 340 | CUE | Cue Biopharma, Inc. | 123.79M | 5.97% | 169,195 | 37.66M |
| 341 | NERV | Minerva Neurosciences, Inc. | 120.80M | 9.05% | 194,006 | - |
| 342 | FHTX | Foghorn Therapeutics Inc. | 119.36M | 7.49% | 555,098 | 36.74M |
| 343 | ARMP | Armata Pharmaceuticals, Inc. | 118.98M | 4.23% | 87,387 | 5.54M |
| 344 | BDTX | Black Diamond Therapeutics, Inc. | 118.93M | 14.36% | 2,113,789 | 70.00M |
| 345 | SPRB | Spruce Biosciences, Inc. | 118.50M | 2.05% | 52,570 | 697.00K |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 113.35M | -0.38% | 1,348,542 | 3.39M |
| 347 | HUMA | Humacyte, Inc. | 112.79M | 1.22% | 4,892,853 | 2.12M |
| 348 | HURA | TuHURA Biosciences, Inc. | 112.16M | -1.12% | 39,100 | - |
| 349 | GNLX | Genelux Corporation | 112.03M | 2.04% | 331,695 | 8.00K |
| 350 | ENGN | enGene Therapeutics Inc. | 111.92M | 5.70% | 1,119,791 | - |
| 351 | SEER | Seer, Inc. | 109.64M | -1.98% | 553,735 | 14.22M |
| 352 | KZIA | Kazia Therapeutics Limited | 107.99M | 0.38% | 168,237 | 1.27M |
| 353 | TVGN | Tevogen Inc. | 107.32M | 0.74% | 1,699 | - |
| 354 | CBUS | Cibus, Inc. | 106.24M | 5.34% | 56,948 | 4.35M |
| 355 | UNCY | Unicycive Therapeutics, Inc. | 105.85M | 8.26% | 1,192,912 | - |
| 356 | PMVP | PMV Pharmaceuticals, Inc. | 104.96M | 10.76% | 347,568 | - |
| 357 | PYPD | PolyPid Ltd. | 104.61M | 5.53% | 109,506 | - |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 104.43M | 1.00% | 10,811,447 | 65.34K |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 101.24M | 2.63% | 502,307 | 2.34M |
| 360 | IMUX | Immunic, Inc. | 101.11M | 6.01% | 429,638 | - |
| 361 | VANI | Vivani Medical, Inc. | 101.03M | 0.89% | 89,566 | - |
| 362 | LENZ | LENZ Therapeutics, Inc. | 100.23M | -3.33% | 819,364 | 21.48M |
| 363 | TNXP | Tonix Pharmaceuticals Holding Corp. | 99.13M | 0.87% | 752,358 | 29.10M |
| 364 | COYA | Coya Therapeutics, Inc. | 98.76M | 0.24% | 82,888 | 8.02M |
| 365 | NRXS | NeurAxis, Inc. | 98.20M | -0.38% | 57,880 | 5.32M |
| 366 | OKUR | OnKure Therapeutics, Inc. | 95.57M | 4.89% | 235,145 | - |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 95.21M | -0.52% | 10,085 | - |
| 368 | ICCC | ImmuCell Corporation | 94.91M | -0.57% | 4,037 | 30.68M |
| 369 | TENX | Tenax Therapeutics, Inc. | 93.37M | 7.24% | 1,459,076 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 93.17M | 2.68% | 166,785 | - |
| 371 | ATRA | Atara Biotherapeutics, Inc. | 91.95M | 2.23% | 14,832 | 6.19M |
| 372 | TNYA | Tenaya Therapeutics, Inc. | 91.93M | 8.58% | 3,261,737 | 1.34M |
| 373 | RANI | Rani Therapeutics Holdings, Inc. | 91.00M | 0.38% | 458,996 | 4.88M |
| 374 | EQ | Equillium, Inc. | 87.50M | 11.29% | 774,543 | 4.39M |
| 375 | NMRA | Neumora Therapeutics, Inc. | 87.37M | -1.06% | 974,509 | - |
| 376 | RLYB | Rallybio Corporation | 86.99M | 0.18% | 4,664 | 646.00K |
| 377 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 85.49M | -0.90% | 477,636 | - |
| 378 | AARD | Aardvark Therapeutics, Inc. | 85.35M | 4.28% | 66,694 | - |
| 379 | CNXU | Conexeu Sciences Inc. | 84.34M | -9.12% | 597,135 | - |
| 380 | PTHS | Pelthos Therapeutics Inc. | 78.48M | 1.18% | 75,950 | 43.30M |
| 381 | CLLS | Cellectis S.A. | 77.55M | 6.97% | 281,754 | 63.82M |
| 382 | ACRV | Acrivon Therapeutics, Inc. | 76.92M | 6.21% | 185,409 | - |
| 383 | TELO | Telomir Pharmaceuticals, Inc. | 74.35M | -2.88% | 78,957 | - |
| 384 | PMN | ProMIS Neurosciences, Inc. | 72.55M | -1.70% | 30,253 | - |
| 385 | CRDF | Cardiff Oncology, Inc. | 72.47M | 5.17% | 595,471 | 508.00K |
| 386 | OKYO | OKYO Pharma Limited | 71.90M | -2.14% | 49,611 | - |
| 387 | NTRB | Nutriband Inc. | 71.11M | 0.83% | 16,060 | 1.62M |
| 388 | SPRO | Spero Therapeutics, Inc. | 71.05M | 8.93% | 679,284 | 47.00M |
| 389 | CGTX | Cognition Therapeutics, Inc. | 69.78M | 0.88% | 461,530 | - |
| 390 | PDSB | PDS Biotechnology Corporation | 69.61M | 4.80% | 4,058,154 | - |
| 391 | NTHI | NeOnc Technologies Holdings, Inc. | 68.85M | 1.84% | 102,339 | 39.99K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 68.12M | 4.67% | 184,536 | - |
| 393 | HRTX | Heron Therapeutics, Inc. | 67.30M | -1.77% | 1,475,120 | 151.18M |
| 394 | CSBR | Champions Oncology, Inc. | 66.95M | 2.56% | - | 60.66M |
| 395 | MNOV | MediciNova, Inc. | 66.94M | -2.14% | 37,087 | 920.48K |
| 396 | CING | Cingulate Inc. | 65.87M | 3.90% | 108,281 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 64.70M | 3.74% | 293,893 | 68.47M |
| 398 | ONCY | Oncolytics Biotech Inc. | 63.58M | 0.46% | 1,198,329 | - |
| 399 | XBIT | XBiotech Inc. | 61.59M | 1.00% | 41,227 | - |
| 400 | HYFT | MindWalk Holdings Corp. | 60.77M | -2.27% | 240,909 | 11.57M |
| 401 | VRCA | Verrica Pharmaceuticals Inc. | 59.61M | 0.87% | 77,182 | 30.32M |
| 402 | GOSS | Gossamer Bio, Inc. | 58.60M | 13.64% | 214,499 | 53.29M |
| 403 | OSTX | OS Therapies Incorporated | 58.22M | -0.79% | 320,657 | - |
| 404 | PLRX | Pliant Therapeutics, Inc. | 56.50M | 1.52% | 319,683 | - |
| 405 | XLO | Xilio Therapeutics, Inc. | 56.19M | 2.52% | 13,506 | 64.09M |
| 406 | CRBU | Caribou Biosciences, Inc. | 55.64M | 11.85% | 3,411,959 | 10.04M |
| 407 | BOLD | Boundless Bio, Inc. | 55.27M | 5.19% | 89,737 | - |
| 408 | CNTB | Connect Biopharma Holdings Limited | 55.12M | -2.73% | 339,510 | 2.95M |
| 409 | ALPS | Alps Group Inc | 54.91M | -2.94% | 44,432 | 3.74M |
| 410 | RNXT | RenovoRx, Inc. | 54.16M | 3.45% | 264,532 | 1.98M |
| 411 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.36M | 5.76% | 18,937 | - |
| 412 | BMEA | Biomea Fusion, Inc. | 53.32M | -11.96% | 3,550,937 | - |
| 413 | CLNN | Clene Inc. | 53.02M | 13.37% | 201,978 | 197.00K |
| 414 | IBIO | iBio, Inc. | 52.80M | 8.01% | 2,215,991 | 100.00K |
| 415 | GANX | Gain Therapeutics, Inc. | 51.94M | -4.80% | 517,004 | - |
| 416 | RNTX | Rein Therapeutics Inc. | 51.34M | 7.81% | 296,342 | - |
| 417 | HOWL | Werewolf Therapeutics, Inc. | 51.03M | 0.96% | 485,725 | 21.00M |
| 418 | INKT | MiNK Therapeutics, Inc. | 50.32M | 3.14% | 8,415 | - |
| 419 | LONA | LeonaBio, Inc. | 49.65M | 4.36% | 61,514 | - |
| 420 | KLRS | Kalaris Therapeutics, Inc. | 49.28M | 8.38% | 51,407 | - |
| 421 | ACET | Adicet Bio, Inc. | 48.65M | -0.22% | 126,511 | - |
| 422 | APLM | Apollomics, Inc. | 48.42M | -0.01% | 352 | 8.84M |
| 423 | MREO | Mereo BioPharma Group plc | 47.12M | -2.32% | 494,044 | 500.00K |
| 424 | IMA | ImageneBio, Inc. | 46.88M | 1.25% | 22,003 | 800.00K |
| 425 | HYPD | Hyperion DeFi, Inc. | 46.23M | 4.02% | 270,154 | 1.40M |
| 426 | INMB | INmune Bio Inc. | 44.41M | 3.90% | 75,599 | 50.00K |
| 427 | ALDX | Aldeyra Therapeutics, Inc. | 44.30M | 10.40% | 1,650,613 | - |
| 428 | ATNM | Actinium Pharmaceuticals, Inc. | 44.02M | 6.06% | 901,051 | 35.09M |
| 429 | ATHE | Alterity Therapeutics Limited | 43.31M | - | 17,732 | 2.50M |
| 430 | SER | Serina Therapeutics, Inc. | 42.16M | 0.61% | - | 130.00K |
| 431 | ANVS | Annovis Bio, Inc. | 41.68M | 1.91% | 703,977 | - |
| 432 | GRCE | Grace Therapeutics, Inc. | 41.65M | 5.32% | 94,375 | - |
| 433 | ELTX | Elicio Therapeutics, Inc. | 41.26M | 1.29% | 275,818 | - |
| 434 | IRLA | IRulya Therapeutics Inc. | 40.96M | 16.89% | 316,902 | - |
| 435 | CELU | Celularity Inc. | 40.89M | 8.62% | 60,138 | 18.97M |
| 436 | VERU | Veru Inc. | 40.58M | 3.03% | 89,580 | 16.89M |
| 437 | TIL | Instil Bio, Inc. | 40.28M | 2.59% | 100,111 | - |
| 438 | DWTX | Dogwood Therapeutics, Inc. | 39.09M | -4.96% | 50,345 | - |
| 439 | EXOZ | eXoZymes, Inc. | 38.24M | 3.00% | 4,313 | -700.00 |
| 440 | EDSA | Edesa Biotech, Inc. | 38.10M | 1.44% | 35,414 | - |
| 441 | NNVC | NanoViricides, Inc. | 37.78M | 13.85% | 464,098 | - |
| 442 | LITS | Lite Strategy, Inc. | 36.18M | 2.59% | 225,247 | - |
| 443 | EYPT | EyePoint, Inc. | 34.93M | -7.91% | 51,026,506 | 2.79M |
| 444 | CRVO | CervoMed Inc. | 34.62M | -0.87% | 136,346 | 331.30K |
| 445 | EVAX | Evaxion A/S | 33.78M | 21.62% | 535,363 | 7.49M |
| 446 | FLNA | Filana Therapeutics, Inc. | 33.26M | 0.95% | 198,341 | - |
| 447 | GRDX | GridAI Technologies Corp. | 32.79M | 5.47% | 95,343 | - |
| 448 | ALGS | Aligos Therapeutics, Inc. | 31.41M | 3.93% | 42,814 | 31.52M |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 31.40M | 2.40% | 94,110 | 13.56M |
| 450 | BSEM | BioStem Technologies, Inc. | 30.48M | 6.49% | 163,364 | 34.59M |
| 451 | BCTX | BriaCell Therapeutics Corp. | 30.10M | 2.37% | 35,788 | - |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 28.44M | -1.18% | 19,869 | - |
| 453 | IBO | Impact BioMedical Inc. | 27.92M | 6.78% | - | 35.00K |
| 454 | CVM | CEL-SCI Corporation | 27.26M | -6.06% | 140,468 | - |
| 455 | ATOS | Atossa Therapeutics, Inc. | 25.35M | -0.78% | 36,755 | - |
| 456 | IGC | IGC Pharma, Inc. | 25.33M | 1.24% | 447,569 | 1.11M |
| 457 | NXTC | NextCure, Inc. | 24.90M | -4.06% | 82,034 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 24.11M | 2.20% | 11,797 | 797.92K |
| 459 | IMMP | Immutep Limited | 23.73M | 2.84% | 16,362 | 13.79M |
| 460 | MCRB | Seres Therapeutics, Inc. | 23.20M | -4.55% | 66,979 | 1.88M |
| 461 | CNTX | Context Therapeutics Inc. | 22.40M | 2.27% | 732,856 | - |
| 462 | PLRZ | Polyrizon Ltd. | 22.22M | -5.57% | 15,873 | - |
| 463 | BYSI | BeyondSpring Inc. | 21.49M | 1.91% | 65,801 | 1.88M |
| 464 | KYNB | Kyntra Bio, Inc. | 21.38M | - | 13,547 | 4.62M |
| 465 | AKTX | Akari Therapeutics, Plc | 21.23M | -6.07% | 35,118 | - |
| 466 | QNTM | Quantum BioPharma Ltd. | 19.65M | 0.83% | 51,176 | - |
| 467 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.41M | 1.51% | 8,062 | - |
| 468 | MRKR | Marker Therapeutics, Inc. | 19.34M | -3.33% | 209,417 | 3.55M |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.34M | 2.42% | - | 1.17M |
| 470 | COCP | Cocrystal Pharma, Inc. | 18.16M | -0.39% | 15,344 | 330.00K |
| 471 | GUTS | Fractyl Health, Inc. | 17.64M | -3.62% | 477,955 | 3.00K |
| 472 | ESLA | Estrella Immunopharma, Inc. | 17.40M | 5.29% | 194,371 | - |
| 473 | ATYR | aTyr Pharma, Inc. | 17.00M | 0.93% | 1,321,175 | 190.00K |
| 474 | JSPR | Jasper Therapeutics, Inc. | 16.63M | 4.71% | 366,523 | - |
| 475 | PBM | Psyence Biomedical Ltd. | 16.17M | 2.91% | 44,403 | - |
| 476 | ICU | SeaStar Medical Holding Corporation | 16.05M | -1.93% | 107,542 | 1.71M |
| 477 | BCDA | BioCardia, Inc. | 15.74M | 15.88% | 217,687 | 3.00K |
| 478 | TCRX | TScan Therapeutics, Inc. | 15.18M | 6.57% | 559,545 | 7.11M |
| 479 | NCEL | NewcelX Ltd. | 15.08M | -0.76% | 9,409 | - |
| 480 | KPRX | Kiora Pharmaceuticals, Inc. | 14.83M | -2.10% | 23,455 | 20.00K |
| 481 | ACTU | Actuate Therapeutics, Inc. | 14.80M | 2.85% | 166,654 | - |
| 482 | DYAI | Dyadic International, Inc. | 14.03M | 1.10% | - | 3.80M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 13.93M | 0.32% | 108,498 | 345.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 13.70M | -0.56% | 38,497 | - |
| 485 | DARE | Daré Bioscience, Inc. | 13.55M | -2.41% | 217,677 | 1.37M |
| 486 | LPCN | Lipocine Inc. | 13.36M | 5.88% | 246,500 | 1.57M |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 13.23M | 2.27% | 195,186 | - |
| 488 | GTBP | GT Biopharma, Inc. | 13.19M | 9.27% | 49,369 | - |
| 489 | HIND | Vyome Holdings, Inc. | 12.91M | - | 8,246 | 129.73K |
| 490 | CNSY | Cerenome, Inc. | 12.75M | 1.82% | 76,916 | 4.20M |
| 491 | RADX | Radiopharm Theranostics Limited | 12.15M | 2.80% | 31,426 | 8.90M |
| 492 | CLRB | Cellectar Biosciences, Inc. | 11.63M | 9.82% | 109,491 | - |
| 493 | PASG | Passage Bio, Inc. | 11.58M | 0.56% | 5,660 | - |
| 494 | AEON | AEON Biopharma, Inc. | 11.55M | 0.22% | 310,153 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 11.46M | -2.41% | 187,988 | 7.11M |
| 496 | INAB | IN8bio, Inc. | 11.24M | 4.59% | 2,376 | - |
| 497 | PLUR | Pluri Inc. | 11.11M | 5.87% | 12,501 | 1.02M |
| 498 | INTS | Intensity Therapeutics, Inc. | 10.71M | -0.30% | 2,190 | - |
| 499 | BLRX | BioLineRx Ltd. | 10.63M | 11.84% | 3,055 | 1.39M |
| 500 | PPBT | Purple Biotech Ltd | 10.49M | 0.46% | 15,424 | - |